In preclinical models of neurological disease, NGF treatment reverses the effects of lesions and age-related degeneration of basal forebrain cholinergic neurons, including the recovery of learning and memory (Tuszynski and Blesch, 2004). This evidence concerns the gene NGF and nervous system disorder.